Article
Ridgefield, CT—Eschenbach Optik of America Inc. is changing its senior management team with the promotion of its ophthalmic division president to company president.
Survey reveals gaps in patient awareness of preservative-free glaucoma treatments
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
Harrow to enact a 5-year strategic supply and development agreement for triamcinolone acetonide injectable suspension
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Choroidal vascularity index offers insight into eye health after COVID-19 recovery
FDA accepts new drug application for low-dose atropine from Sydnexis